256 results
Page 7 of 13
6-K
EX-99.1
id0c4p5dc3
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
CORRESP
dn723wgrneqb5vsm
6 Jan 15
Correspondence with SEC
12:00am
6-K
EX-99.1
26i3d mzolsiikwigrue
22 Dec 14
Current report (foreign)
12:00am
6-K
EX-99.2
46en7ikjj
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.4
r46vuwxtk1b 09t28v
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.3
bq9766ppm88wq0
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
c9rkj60f9cc ubzt42vf
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
44q xoklim
9 Oct 14
RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum
12:00am
6-K
EX-99.1
d4qtvfl8g lqp1zx9
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
286ot iidw
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.3
wxhtu q2u6q6o
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.4
6s9188fehcv7y
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
eu51rb 7wekz7xi2dw
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.4
taw2d
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
j85y29i37n 91c4g1n
29 May 14
Current report (foreign)
12:00am